Curated coverage for fda with top developments, timeline context, and connected threads.
Getting patients to take daily cholesterol-lowering drugs is one of medicine's biggest challenges. Gene editing could solve it with a single treatment. Here is the science, the trials, and what comes next.
Bulk Importer | Linked source
MDMA-assisted therapy is under FDA review, psilocybin is legal for therapy in several states, and ketamine clinics are opening everywhere. Here is the honest state of the science.
EuroBulletin24 Editorial Desk | Linked source
Suzetrigine (Journavax) was FDA-approved in January 2025 and is now reshaping pain management. Here is what it is, how it works differently from opioids, and who it could help.
GLP-1 drugs like Ozempic won FDA approvals for addiction, kidney disease, and heart failure in 2026. Here is the full science behind what these drugs are actually doing to the human body.